» Articles » PMID: 29121146

Association Between Head and Neck Squamous Cell Carcinoma Survival, Smoking at Diagnosis, and Marital Status

Overview
Date 2017 Nov 10
PMID 29121146
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Importance: While the adverse association between smoking and head and neck squamous cell carcinoma (HNSCC) survival has been well described, there are also inconclusive studies and those that report no significant changes in HNSCC survival and overall mortality due to smoking. There is also a lack of studies investigating the association of marital status on smoking status at diagnosis for patients with HNSCC.

Objective: To examine the association between patient smoking status at HNSCC diagnosis and survival and the association between marital status and smoking in these patients.

Design, Setting, And Participants: This retrospective cohort study was conducted by querying the Saint Louis University Hospital Tumor Registry for adults with a diagnosis of HNSCC and treated at the university academic medical center between 1997 and 2012; 463 confirmed cases were analyzed.

Main Outcomes And Measures: Cox proportional hazards regression analysis was used to evaluate association of survival with smoking status at diagnosis and covariates. A multivariate logistic regression model was used to assess whether marital status was associated with smoking at diagnosis adjusting for covariates.

Results: Of the 463 total patients (338 men, 125 women), 92 (19.9%) were aged 18 to 49 years; 233 (50.3%) were aged 50 to 65 years; and 138 (29.8%) were older than 65 years. Overall, 56.2% of patients were smokers at diagnosis (n = 260); 49.6% were married (n = 228); and the mortality rate was 54.9% (254 died). A majority of patients were white (81.0%; n = 375). Smokers at diagnosis were more likely to be younger (ie, <65 years), unmarried, and to drink alcohol. We found a statistically significant difference in median survival time between smokers (89 months; 95% CI, 65-123 months) and nonsmokers at diagnosis (208 months; 95% CI, 129-235 months). In the adjusted Cox proportional hazards model, patients who were smokers at diagnosis were almost twice as likely to die during the study period as nonsmokers (hazard ratio, 1.98; 95% CI, 1.42-2.77). In the multivariate logistic regression analysis, unmarried patients were 76% more likely to use tobacco than married patients (adjusted odds ratio, 1.76; 95% CI, 1.08-2.84).

Conclusions And Relevance: Smokers were almost twice as likely as nonsmokers to die during the study period. We also found that those who were married were less likely to be smokers at diagnosis. Our study suggests that individualized cancer care should incorporate social support and management of cancer risk behaviors.

Citing Articles

Racioethnic disparities in comorbidities and outcomes following head and neck oncologic surgery.

Waqar U, Arif A, Hameed A, Zaidi S, Hamza M, Iftikhar H World J Otorhinolaryngol Head Neck Surg. 2025; 11(1):74-85.

PMID: 40070499 PMC: 11891266. DOI: 10.1002/wjo2.178.


Genetic and Molecular Differences in Head and Neck Cancer Based on Smoking History.

Jiang R, Gao M, Chen M, Weatherspoon D, Watts T, Osazuwa-Peters N JAMA Otolaryngol Head Neck Surg. 2025; .

PMID: 40048195 PMC: 11886874. DOI: 10.1001/jamaoto.2024.5409.


Performance of 8 Smoking Metrics for Modeling Survival in Head and Neck Squamous Cell Carcinoma.

Lam A, Hueniken K, Pienkowski M, Lee J, Dong M, Diergaarde B JAMA Otolaryngol Head Neck Surg. 2025; .

PMID: 39976935 PMC: 11843462. DOI: 10.1001/jamaoto.2024.5392.


Prognostic model for overall survival of head and neck cancer patients in the palliative phase.

Hoesseini A, Sewnaik A, van den Besselaar B, Zhang J, van Leeuwen N, Hardillo J BMC Palliat Care. 2024; 23(1):54.

PMID: 38395897 PMC: 10893612. DOI: 10.1186/s12904-023-01325-y.


Dietary intervention for tertiary prevention in head and neck squamous cell carcinoma survivors: clinical and translational results of a randomized phase II trial.

Cavalieri S, Bruno E, Serafini M, Lenoci D, Canevari S, Lopez-Perez L Front Oncol. 2024; 13:1321174.

PMID: 38239654 PMC: 10794719. DOI: 10.3389/fonc.2023.1321174.


References
1.
Karam-Hage M, Cinciripini P, Gritz E . Tobacco use and cessation for cancer survivors: an overview for clinicians. CA Cancer J Clin. 2014; 64(4):272-90. PMC: 4377321. DOI: 10.3322/caac.21231. View

2.
Smith E, Rubenstein L, Haugen T, Hamsikova E, Turek L . Tobacco and alcohol use increases the risk of both HPV-associated and HPV-independent head and neck cancers. Cancer Causes Control. 2010; 21(9):1369-78. DOI: 10.1007/s10552-010-9564-z. View

3.
Lopez R, Zago M, Eluf-Neto J, Curado M, Daudt A, da Silva-Junior W . Education, tobacco smoking, alcohol consumption, and IL-2 and IL-6 gene polymorphisms in the survival of head and neck cancer. Braz J Med Biol Res. 2011; 44(10):1006-12. DOI: 10.1590/s0100-879x2011007500097. View

4.
McCarter K, Martinez U, Britton B, Baker A, Bonevski B, Carter G . Smoking cessation care among patients with head and neck cancer: a systematic review. BMJ Open. 2016; 6(9):e012296. PMC: 5051538. DOI: 10.1136/bmjopen-2016-012296. View

5.
Warnakulasuriya S . Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2008; 45(4-5):309-16. DOI: 10.1016/j.oraloncology.2008.06.002. View